GlaxoSmithKline makes bold move with £130m Covid-19 investment | Nils Pratley

  • 📰 The Guardian
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 53%

Indonesia Berita Berita

Indonesia Berita Terbaru,Indonesia Berita utama

GSK’s share price has been left standing by AstraZeneca’s high-risk success in cancer treatments

Monday’s most important vaccine news was the promising early data from the Oxford University and AstraZeneca coronavirus trial – “robust immune responses” is encouraging. But let’s not overlook other vaccine developments. The industry has been viewed for years as a dull subsector of the pharmaceutical business; now it is a whir of deal-making activity.

 

Terima kasih atas komentar Anda. Komentar Anda akan dipublikasikan setelah ditinjau.

Bold? With Lord Backsheesh Of Durham At Barnham Castle?

Fuck your poison dart. We know the shite that is in it. The people are waking up!

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

 /  🏆 84. in İD

Indonesia Berita Terbaru, Indonesia Berita utama